Replies to post #439927 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

The Stupp data from 2005 only tested mgmt status in 25% of patients. It is really a useless trial to rely upon anything from for matching purposes. There are plenty of trials that started enrolling after our trial that tested for idh1 status.